New resource available  view now

Genetic Toxicity Evaluation of Melatonin in the Bacterial Reverse Mutation Assay

We are presenting a poster named “Genetic Toxicity Evaluation of Melatonin in the Bacterial Reverse Mutation Assay”  at The Genetic Toxicology Association (GTA) Meeting 2025 held at the Clayton Hall Conference Center on the Campus of the University of Delaware in Newark from May 7 – 9, where we concluded that melatonin exhibited no evidence of genotoxic activity under a Bacterial Reverse Mutation Test, supporting its safety profile at the tested dose range. These findings contribute to the non-clinical safety assessment of melatonin as part of the IGC-AD1 development program.

Related Posts

Privacy Overview

This website uses cookies and similar tracking technologies to enhance your browsing experience, analyze site traffic, provide personalized content, and support marketing activities. These technologies may involve the collection and processing of personal data, including through third-party services. 

In accordance with applicable privacy laws, including the California Consumer Privacy Act (CCPA) and other relevant regulations, you have the right to accept, reject, or customize the use of non-essential cookies, as well as to opt out of the sale or sharing of your personal information for targeted advertising. 

You can manage your preferences at any time through our cookie settings panel.